ArticleBMC health services research2026
National trends in the prevalence of dementia in Medicare Advantage and Traditional Medicare.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundLittle is known about how the prevalence of dementia in Medicare Advantage (MA) and traditional Medicare (TM) has changed over time. We examine prevalence of dementia in MA and TM overall and by race/ethnicity, the characteristics of these individuals within plans, as well as enrollment and switching rates between MA and TM between 2000 and 2014.
methodsRepeated cross-sectional study using eight waves from the Health and Retirement Study (HRS) linked to Medicare enrollment data. Sample includes HRS respondents ≥ 65 years of age (n = 18,381) linked to Medicare enrollment data. Measurements used include predicted cognitive function (Langa-Weir classification: dementia, cognitive impairment not dementia, and normal), three race/ethnicity categories (White, Black, and Hispanic), demographic and clinical characteristics from HRS, and Medicare enrollment (MA or TM) per year.
resultsAmong TM enrollees, prevalence of dementia was lower by 4% points in 2014 (9.0%, 95%CI: 7.8%, 9.3%) compared to 2000 (13.0%, 95%CI: 12%, 14%). The prevalence of dementia in MA was higher by 2% points in 2014 (10.0%, 95%CI: 8.5%, 11%) compared to 2000 (8.0%, 95% CI: 7.2%, 9.7%). Prevalence of dementia in MA remained stable for Whites non-Hispanic, was 2% points higher for Blacks non-Hispanic, and 5% points higher for Hispanics in 2014 compared to 2000. MA compared to TM beneficiaries with dementia in 2014 were younger (mean [SE] 81.6 [0.5] vs. 83.5 [0.4]), had fewer activity of daily living limitations (1.9 [0.1] vs. 2.4 [0.1]), instrumental activities of daily living limitations (2.3 [0.1] vs. 2.8 [0.1]), and of chronic conditions (3.2 [0.1] vs. 3.5 [0.1]). By 1-year (2012–2013), 6.3% of MA beneficiaries with dementia switched to TM and 4.3% of TM beneficiaries with dementia switched to MA.
conclusionsBetween 2000 and 2014, dementia prevalence was lower in TM compared to MA. Evidence suggests that MA beneficiaries with dementia are younger and have fewer functional limitations than their dementia TM counterparts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.